Page 3 - Nimishp Shah News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apogee Therapeutics, Inc (NASDAQ:APGE) Given Average Rating of Buy by Analysts

Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in […]

Nimishp shahStifel nicolausApogee therapeutics incSecurities exchange commissionJefferies financial groupApogee therapeuticsGet free reportDirector nimishExchange commissionTherapeutics stock downGet freeApogee therapeutics dailyNasdaq apge

Apogee Therapeutics, Inc (NASDAQ:APGE) Receives Average Rating of Buy from Analysts

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have covered the stock in the […]

Stifel nicolausNimishp shahApogee therapeutics company profileSecurities exchange commissionApogee therapeutics incJefferies financial groupApogee therapeuticsGet free reportMarketbeat ratingsFinancial groupDirector nimishExchange commissionTherapeutics trading downGet freeApogee therapeutics dailyNasdaq apge

Apogee Therapeutics, Inc s (NASDAQ:APGE) Quiet Period Will End on August 23rd

Apogee Therapeutics, Inc s (NASDAQ:APGE) Quiet Period Will End on August 23rd
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nimishp shahStifel nicolausApogee therapeutics incJefferies financial groupSecurities exchange commissionExchange commissionApogee therapeuticGet free reportApogee therapeuticsFinancial groupDirector nimishApogee therapeutics daily

Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High at $23 16

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as $23.16 and last traded at $23.07, with a volume of 138737 shares traded. The stock had previously closed at $22.22. Wall Street Analyst Weigh In APGE has been the subject of a […]

Stifel nicolausNimishp shahSecurities exchange commissionJefferies financial groupApogee therapeutics incApogee therapeuticsGet free reportFinancial groupDirector nimishExchange commissionApogee therapeutics dailyNasdaq apge

Research Analysts Recent Ratings Updates for Apogee Therapeutics (APGE)

Several brokerages have updated their recommendations and price targets on shares of Apogee Therapeutics (NASDAQ: APGE) in the last few weeks: 8/8/2023 – Apogee Therapeutics is now covered by analysts at TD Cowen. They set an “outperform” rating on the stock. 8/8/2023 – Apogee Therapeutics is now covered by analysts at Wedbush. They set an […]

Nimishp shahStifel nicolausNews ratings for apogee therapeutics inc dailyApogee therapeutics incJefferies financial group incSecurities exchange commissionApogee therapeuticsDirector nimishExchange commissionApogee therapeutics inc dailyNasdaq apge